Cargando…
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: To investigates the effectiveness of curcumin-containing Nanomicelles as a therapeutic supplement in the treatment of patients with COVID-19 and its effect on immune responses balance changes following treatment. TRIAL DESIGN: This study is conducted as a prospective, placebo-controlled...
Autores principales: | Hassaniazad, Mehdi, Inchehsablagh, Behnaz Rahnama, Kamali, Hossein, Tousi, Abdolali, Eftekhar, Ebrahim, Jaafari, Mahmoud Reza, Fathalipour, Mohammad, Nikoofal-Sahlabadi, Sara, Gouklani, Hamed, Alizade, Hesam, Nikpoor, Amin Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578586/ https://www.ncbi.nlm.nih.gov/pubmed/33092653 http://dx.doi.org/10.1186/s13063-020-04824-y |
Ejemplares similares
-
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial
por: Hosseini, Fatemeh Sadat, et al.
Publicado: (2021) -
CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
por: Soleimani, Anvar, et al.
Publicado: (2022) -
Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model
por: Farshidi, Narges, et al.
Publicado: (2022) -
An overview of diarrheagenic Escherichia coli in Iran: A systematic review and meta-analysis
por: Alizade, Hesam, et al.
Publicado: (2019) -
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
por: Hassaniazad, Mehdi, et al.
Publicado: (2020)